Wall St ends lower as taper acceleration worries pile onto virus angst



(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)

* Communications services, utilities lead sector declines

* Technology sector loses least with help from Apple rally

* Fed's Powell floats accelerated bond-buying taper

* U.S. consumer confidence ebbs in November

* Indexes down: Dow 1.86%, S&P 1.90%, Nasdaq 1.55%

By Devik Jain, Ambar Warrick and Sinéad Carew

Nov 30 (Reuters) - Wall Street's main indexes closed lower on Tuesday after Federal Reserve Chair Jerome Powell signaled that the U.S. central bank would consider speeding up its withdrawal of bond purchases as inflation risks increase, piling pressure onto a market already nervous about the latest COVID-19 variant.

In a testimony before the Senate Banking Committee, Powell indicated that he no longer considers high inflation as "transitory" and that the Fed would revisit the timeline for scaling back its bond buying program at its next meeting in two weeks.

"Powell's comments threw a monkey in the wrench in market thinking in terms of potential taper timing. You're seeing as a result of that, risk-off across the board," said Michael James, managing director of equity trading at Wedbush Securities in Los Angeles.

"You also have to factor in the Omicron variant concerns. You can argue whether they're more headline risk or reality risk but regardless, it's having a significant impact on oil, and everything that's tied to economic growth."

Powell's comments also prompted speculation among some investors about a potential acceleration in interest rate hikes.

"The principal contributor to the decline in stock prices today is the Powell commentary, regarding the upcoming Fed meeting, about accelerating the tapering of their bond buying program, which obviously leads to the prospect that rate hikes come sooner next year," said Mark Luschini, chief investment strategist at Janney Montgomery Scott in Philadelphia.

"That somewhat hawkish shift in tone caught the market flatfooted," Luschini said.

Meanwhile, the market was also left waiting for information about how dangerous the Omicron variant might be, the degree to which current vaccinations could offer protection and the additional restrictions governments might have to impose that could hurt the economy, Luschini said.

The Dow Jones Industrial Average .DJI fell 652.22 points, or 1.86%, to 34,483.72, the S&P 500 .SPX lost 88.27 points, or 1.90%, to 4,567 and the Nasdaq Composite .IXIC dropped 245.14 points, or 1.55%, to 15,537.69.

For the month, the S&P registered a decline of 0.8%, while the Dow dropped 3.7% and the Nasdaq eked out a 0.25% gain.

Only seven of the benchmark S&P 500 components gained ground on Tuesday.

For the day, all the 11 major S&P industry sectors fell with seven of those sectors falling more than 2%. Communication services .SPLRCL lead the losses with a 3% drop followed by Utilities' .SPLRCU 2.9% drop. As oil prices tumbled, energy .SPNY were under pressure throughout the session, closing down 2.5%.

The top performer was information technology .SPLRCT , falling just 0.96%, with help from Apple Inc AAPL.O , which boasted a recording closing high and a 3.2% gain for the day.

Tuesday's decline was a sharp reversal after Monday's rally in which stocks regained some ground they had lost on Friday when the market sold-off swiftly on news of the virus variant.

"The market is clearly in some treacherous waters right now. You've had two significant pullbacks out of the last three trading days. This is certainly shaking some of the complacent longs in the market," said Wedbush's James.

While the Food and Drug Administration said it hopes to have information about the effectiveness of current COVID-19 vaccines against Omicron, vaccine companies were divided.

BioNTech's 22UAy.DE chief executive said the vaccine his company supplies in partnership with Pfizer PFE.N will likely offer strong protection from severe illness in variant cases. But Moderna Inc's MRNA.O CEO told the Financial Times that COVID-19 shots are unlikely to be as effective against the new variant as they have been previously.

Moderna shares fell 4.4% while Regeneron Pharmaceuticals Inc REGN.O lost 2.7% after it said its COVID-19 antibody treatment and other similar drugs could be less effective against Omicron.

Travel and leisure stocks slumped, with the S&P 1500 Hotels, Restaurant and Leisure .SPCOMHRL indexes fell more than 2% while the S&P 1500 Airlines .SPCOMAIR index lost 0.6%.

The small-cap Russell 2000 index .RUT fell 1.9%.

The virus uncertainty has triggered fresh alarm at a time when supply chain logjams are weighing on economic recovery and central banks globally are contemplating a return to pre-pandemic monetary policy to tackle a surge in inflation.

Meanwhile, data showed U.S. consumer confidence slipped in November amid concerns about the rising cost of living and relentless COVID-19 pandemic.

Declining issues outnumbered advancing ones on the NYSE by a 3.82-to-1 ratio; on Nasdaq, a 2.40-to-1 ratio favored decliners.

The S&P 500 posted seven new 52-week highs and 45 new lows; the Nasdaq Composite recorded 28 new highs and 572 new lows.

Tuesday registered the highest volume trading session for U.S. exchanges since June with 16.13 billion shares changing hands, compared with the 11.12 billion moving average for the last 20 sessions.
Reporting by Devik Jain and Ambar Warrick in Bengaluru, Sinéad Carew in New York, Kevin Buckland in Ottawa, Editing by Marguerita Choy and Sriraj Kalluvila

免責聲明: XM Group提供線上交易平台的登入和執行服務,允許個人查看和/或使用網站所提供的內容,但不進行任何更改或擴展其服務和訪問權限,並受以下條款與條例約束:(i)條款與條例;(ii)風險提示;(iii)完全免責聲明。網站內部所提供的所有資訊,僅限於一般資訊用途。請注意,我們所有的線上交易平台內容並不構成,也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。

所有缐上交易平台所發佈的資料,僅適用於教育/資訊類用途,不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議,或是交易價格紀錄,或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。

本網站的所有XM和第三方所提供的内容,包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接,皆爲‘按原狀’,並作爲一般市場評論所提供,而非投資建議。請理解和接受,所有被歸類為投資研究範圍的相關内容,並非爲了促進投資研究獨立性,而根據法律要求所編寫,而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊,相關詳情請點擊 這裡查看。

我們運用 cookies 提供您最佳之網頁使用經驗。更改您的cookie 設定跟詳情。

風險提示: 您的資金存在風險。杠杆商品可能不適合所有客戶。 請詳細閱讀我們的風險聲明